Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

PI3Kδ activates E2F1 synthesis in response to mRNA translation stress

SV. Gnanasundram, S. Pyndiah, C. Daskalogianni, K. Armfield, K. Nylander, JB. Wilson, R. Fåhraeus,

. 2017 ; 8 (1) : 2103. [pub] 20171213

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19001042

The c-myc oncogene stimulates ribosomal biogenesis and protein synthesis to promote cellular growth. However, the pathway by which cells sense and restore dysfunctional mRNA translation and how this is linked to cell proliferation and growth is not known. We here show that mRNA translation stress in cis triggered by the gly-ala repeat sequence of Epstein-Barr virus (EBV)-encoded EBNA1, results in PI3Kδ-dependent induction of E2F1 mRNA translation with the consequent activation of c-Myc and cell proliferation. Treatment with a specific PI3Kδ inhibitor Idelalisib (CAL-101) suppresses E2F1 and c-Myc levels and causes cell death in EBNA1-induced B cell lymphomas. Suppression of PI3Kδ prevents E2F1 activation also in non-EBV-infected cells. These data illustrate an mRNA translation stress-response pathway for E2F1 activation that is exploited by EBV to promote cell growth and proliferation, offering new strategies to treat EBV-carrying cancers.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001042
003      
CZ-PrNML
005      
20190108130152.0
007      
ta
008      
190107s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-017-02282-w $2 doi
035    __
$a (PubMed)29235459
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Gnanasundram, Sivakumar Vadivel $u Inserm UMRS1162, Equipe Labellisée la Ligue Contre le Cancer, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010, Paris, France.
245    10
$a PI3Kδ activates E2F1 synthesis in response to mRNA translation stress / $c SV. Gnanasundram, S. Pyndiah, C. Daskalogianni, K. Armfield, K. Nylander, JB. Wilson, R. Fåhraeus,
520    9_
$a The c-myc oncogene stimulates ribosomal biogenesis and protein synthesis to promote cellular growth. However, the pathway by which cells sense and restore dysfunctional mRNA translation and how this is linked to cell proliferation and growth is not known. We here show that mRNA translation stress in cis triggered by the gly-ala repeat sequence of Epstein-Barr virus (EBV)-encoded EBNA1, results in PI3Kδ-dependent induction of E2F1 mRNA translation with the consequent activation of c-Myc and cell proliferation. Treatment with a specific PI3Kδ inhibitor Idelalisib (CAL-101) suppresses E2F1 and c-Myc levels and causes cell death in EBNA1-induced B cell lymphomas. Suppression of PI3Kδ prevents E2F1 activation also in non-EBV-infected cells. These data illustrate an mRNA translation stress-response pathway for E2F1 activation that is exploited by EBV to promote cell growth and proliferation, offering new strategies to treat EBV-carrying cancers.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné linie $7 D002460
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x genetika $7 D049109
650    _2
$a fosfatidylinositol-3-kinasy třídy I $x genetika $x metabolismus $7 D058534
650    _2
$a transkripční faktor E2F1 $x genetika $x metabolismus $7 D050687
650    _2
$a virus Epsteinův-Barrové - jaderné antigeny $x genetika $x metabolismus $7 D019309
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a virus Epsteinův-Barrové $x genetika $x fyziologie $7 D004854
650    _2
$a interakce hostitele a patogenu $x genetika $7 D054884
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a nádory $x genetika $x patologie $x virologie $7 D009369
650    12
$a proteosyntéza $7 D014176
650    _2
$a messenger RNA $x genetika $7 D012333
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pyndiah, Slovénie $u Inserm UMRS1162, Equipe Labellisée la Ligue Contre le Cancer, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010, Paris, France.
700    1_
$a Daskalogianni, Chrysoula $u Inserm UMRS1162, Equipe Labellisée la Ligue Contre le Cancer, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010, Paris, France.
700    1_
$a Armfield, Kate $u School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
700    1_
$a Nylander, Karin $u Department of Medical Biosciences, Umeå University, Building 6M, SE-901 85, Umeå, Sweden.
700    1_
$a Wilson, Joanna B $u School of Life Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.
700    1_
$a Fåhraeus, Robin $u Inserm UMRS1162, Equipe Labellisée la Ligue Contre le Cancer, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010, Paris, France. robin.fahraeus@inserm.fr. Department of Medical Biosciences, Umeå University, Building 6M, SE-901 85, Umeå, Sweden. robin.fahraeus@inserm.fr. RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic. robin.fahraeus@inserm.fr.
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 8, č. 1 (2017), s. 2103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29235459 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190108130353 $b ABA008
999    __
$a ok $b bmc $g 1364989 $s 1039165
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 8 $c 1 $d 2103 $e 20171213 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Archiving options